Acurx Pharmaceuticals, Inc. ACXP 深 沪
已收盘 02-06 16:00:00 美东时间
2.19
+0.130
+6.31%
华盛通- 最 高2.2601
- 今 开2.03
- 成交量 4.45万股
- 最 低 1.96
- 昨 收 2.06
- 总市值 557.73万
- 52周最高 21.00
- 市盈率 静 --
- 换手率 1.75%
- 52周最低 1.89
- 委 比 75.00%
- 总股本 254.67万
- 历史最高 176.40
- 量 比 0.85
- 振 幅 14.57%
- 历史最低 1.89
- 每 手 1
- 风险率 3.34%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多USPTO Grants Acurx Pharmaceuticals New Patent for DNA Polymerase IIIC Inhibitors
STATEN ISLAND, N.Y., Feb. 2, 2026 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of smal...
02-02 21:00
New to The Street Show #702 Airs Today on Bloomberg at 6:30 PM EST
The show airs as sponsored programming with TV commercials by Synergy CHC, Sust...
2025-11-23 00:20
Acurx Pharmaceuticals Q3 EPS $(1.23) Beats $(1.31) Estimate
Acurx Pharmaceuticals (NASDAQ:ACXP) reported quarterly losses of $(1.23) per share which beat the analyst consensus estimate of $(1.31) by 6.11 percent. This is a 64.35 percent increase over losses of $(3.45) per share
2025-11-12 20:02
Earnings Scheduled For November 12, 2025
Companies Reporting Before The Bell • Hudbay Minerals (NYSE:HBM) is projected t...
2025-11-12 19:11
Acurx Pharmaceuticals Presents Data On Ibezapolstat Clinical Study Program At Diseases Society of America In Atlanta
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), is a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections. It announced today
2025-10-28 20:19
Acurx Pharma Secures Australian Patent For DNA Polymerase IIIC Inhibitors, Expanding ACX-375C Coverage Across Five Countries
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule
2025-10-09 19:35
Australian Patent Office Grants Acurx Patent for DNA Polymerase IIIC Inhibitors
STATEN ISLAND, N.Y., Oct. 9, 2025 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of smal...
2025-10-09 19:30
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Xenetic Biosciences (NASDAQ:XBIO) stock moved upwards by 137.1% to $10...
2025-10-09 01:06
Why Confluent Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
Shares of Confluent Inc (NASDAQ:CFLT) rose sharply in pre-market trading. Confl...
2025-10-08 16:43
美股大行评级 | 潜在涨幅超31%！摩根大通维持通用汽车"超配"评级，目标价从60美元升至80美元
今日重点评级关注：Maxim Group：上调Adial Pharmaceuticals评级至"买入"，目标价1.5美元；BTIG：维持Climb Bio"买入"评级，目标价从7美元升至8美元
2025-10-01 20:13
